DCLK1 has been demonstrated as a cell-of-origin and specific CSC marker in colorectal (CRC) and pancreatic (PC) cancers using lineage-tracing and in vivo imaging [10,11,12,13], and a variety of studies demonstrate its ability to predict relapse, recurrence, and mortality. This evidence concerns the gene DCLK1 and colorectal carcinoma.